Lenuţa-Maria Şuta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lenuţa-Maria Şuta has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Ledeţi
Department of Analytical Chemistry, Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy Timișoara, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania
7 shared publications - Ionuţ Ledeţi
Advanced Instrumental Screening Center, Faculty of Pharmacy, “Victor Babeş” University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timisoara, Romania
7 shared publications - Gabriela Vlase
Research Centre for Thermal Analysis in Environmental Problems/ICAM-Advanced Environmental Research Institute, West University of Timisoara, Oituz Street 4, 300233 Timisoara, Romania
6 shared publications - Titus Vlase
Research Centre for Thermal Analysis in Environmental Problems/ICAM-Advanced Environmental Research Institute, West University of Timisoara, Oituz Street 4, 300233 Timisoara, Romania
5 shared publications - Denisa Circioban
Advanced Instrumental Screening Center, Faculty of Pharmacy, Victor Babeş University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timisoara, Romania
3 shared publications - Laura Sbârcea
Faculty of Pharmacy, “Victor Babeș” University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timișoara, Romania
3 shared publications
Latest Publications
- 8 December 2025
- Published by Springer Nature in Journal of Thermal Analysis and Calorimetry
- Vol. 150 (27) , 22717-22731
Instrumental investigations and preformulation study of the progestin drug desogestrel
- 8 December 2025
- Published by Springer Nature in Journal of Thermal Analysis and Calorimetry
- Vol. 150 (27) , 22717-22731
Instrumental investigations and preformulation study of the progestin drug desogestrel
- Open Access
- 19 April 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (4) , 560
Host–Guest Complexation of Itraconazole with Cyclodextrins for Bioavailability Enhancement
Itraconazole is an antifungal agent included in the triazole pharmacological classification that belongs to the BCS class II, characterized by a low solubility in an aqueous medium (of 1 ng/mL, at neutral pH), which is frequently translated in a low oral bioavailability but with a high permeability. In this sense, it is necessary to find solutions to increase/improve the solubility of itraconazole in the aqueous environment. The main purpose of this study is the preparation and analysis of five different guest–host inclusion complexes containing intraconazole. Initially, a blind docking process was carried out to determine the interactions between itraconazole and the selected cyclodextrins. The second step of the study was to find out if the active pharmaceutical ingredient was entrapped in the cavity of the cyclodextrin, by using spectroscopic and thermal techniques. Also, the antifungal activity of the inclusion complexes was studied to examine if the entrapment of itraconazole influences the therapeutic effect. The results showed that the active substance was entrapped in the cavity of the cyclodextrins, with a molar ratio of 1:3 (itraconazole–cyclodextrin), and that the therapeutic effect was not influenced by the entrapment.
- 19 April 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (4) , 560
Open AccessHost–Guest Complexation of Itraconazole with Cyclodextrins for Bioavailability Enhancement
Itraconazole is an antifungal agent included in the triazole pharmacological classification that belongs to the BCS class II, characterized by a low solubility in an aqueous medium (of 1 ng/mL, at neutral pH), which is frequently translated in a low oral bioavailability but with a high permeability. In this sense, it is necessary to find solutions to increase/improve the solubility of itraconazole in the aqueous environment. The main purpose of this study is the preparation and analysis of five different guest–host inclusion complexes containing intraconazole. Initially, a blind docking process was carried out to determine the interactions between itraconazole and the selected cyclodextrins. The second step of the study was to find out if the active pharmaceutical ingredient was entrapped in the cavity of the cyclodextrin, by using spectroscopic and thermal techniques. Also, the antifungal activity of the inclusion complexes was studied to examine if the entrapment of itraconazole influences the therapeutic effect. The results showed that the active substance was entrapped in the cavity of the cyclodextrins, with a molar ratio of 1:3 (itraconazole–cyclodextrin), and that the therapeutic effect was not influenced by the entrapment.
- Open Access
- 17 January 2024
- Vol. 2023 (2)
Solid-State Characterization of Mupirocin and Metronidazole
Mupirocin is a topical antibiotic widely used to treat various skin infections caused by Gram-positive and Gram-negative bacteria, being the first-line treatment in the case of an infection with methicillin-resistant Staphylococcus aureus (MRSA). Due to the unique mechanism of action, it does not possess any cross-resistance with other antibiotics, leading to its global use in different hospital departments. The main disadvantage of mupirocin is represented by its pharmacokinetic properties, leading to the main purpose of this study, namely, to fully characterize the physicochemical properties of the active pharmaceutical ingredient. Currently, it is used in different combinations with other active substances, for example metronidazole, to decrease the risk of developing resistance to mupirocin and to improve the therapeutic response. This leads to the second purpose of this study, i.e., to characterize the physico-chemical profile of metronidazole and to find out if there are any chemical interactions between the two compounds, and to establish if there is a possibility of using them in the same pharmaceutical formulation, thus increasing the compliance of the patient to the treatment.
- 17 January 2024
- Vol. 2023 (2)
Open AccessSolid-State Characterization of Mupirocin and Metronidazole
Mupirocin is a topical antibiotic widely used to treat various skin infections caused by Gram-positive and Gram-negative bacteria, being the first-line treatment in the case of an infection with methicillin-resistant Staphylococcus aureus (MRSA). Due to the unique mechanism of action, it does not possess any cross-resistance with other antibiotics, leading to its global use in different hospital departments. The main disadvantage of mupirocin is represented by its pharmacokinetic properties, leading to the main purpose of this study, namely, to fully characterize the physicochemical properties of the active pharmaceutical ingredient. Currently, it is used in different combinations with other active substances, for example metronidazole, to decrease the risk of developing resistance to mupirocin and to improve the therapeutic response. This leads to the second purpose of this study, i.e., to characterize the physico-chemical profile of metronidazole and to find out if there are any chemical interactions between the two compounds, and to establish if there is a possibility of using them in the same pharmaceutical formulation, thus increasing the compliance of the patient to the treatment.
- 6 July 2020
- Published by Springer Nature in Journal of Thermal Analysis and Calorimetry
- Vol. 142 (5) , 1951-1961
Instrumental analysis and molecular modelling of inclusion complexes containing artesunate
- 6 July 2020
- Published by Springer Nature in Journal of Thermal Analysis and Calorimetry
- Vol. 142 (5) , 1951-1961
Instrumental analysis and molecular modelling of inclusion complexes containing artesunate
- 19 August 2018
- Published by Springer Nature in Journal of Thermal Analysis and Calorimetry
- Vol. 134 (1) , 757-764
Study of kinetic characteristics of 6-ethyl chenodeoxycholic acid and deoxycholic acid decomposition in non-isothermal conditions
- 19 August 2018
- Published by Springer Nature in Journal of Thermal Analysis and Calorimetry
- Vol. 134 (1) , 757-764
Study of kinetic characteristics of 6-ethyl chenodeoxycholic acid and deoxycholic acid decomposition in non-isothermal conditions
- Open Access
Solid-State Characterization and Biological Activity of Betulonic Acid Derivatives
Betulonic acid belongs to the pentacyclic triterpenic derivative class and can be obtained through the selective oxidation of betulin. In this study we set obtaining several functionalized derivatives of this compound by its condensation with several amino compounds such as aminoguanidine, hydroxylamine, n-butylamine and thiosemicarbazide as our goal. The functionalization of the parent compound led to several molecules with antiproliferative potential, the most promising being 3–2-carbamothioylhydrazonolup-20(29)-en-28-oic acid.
Open AccessSolid-State Characterization and Biological Activity of Betulonic Acid Derivatives
Betulonic acid belongs to the pentacyclic triterpenic derivative class and can be obtained through the selective oxidation of betulin. In this study we set obtaining several functionalized derivatives of this compound by its condensation with several amino compounds such as aminoguanidine, hydroxylamine, n-butylamine and thiosemicarbazide as our goal. The functionalization of the parent compound led to several molecules with antiproliferative potential, the most promising being 3–2-carbamothioylhydrazonolup-20(29)-en-28-oic acid.
- Open Access
- 13 January 2015
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 16 (1) , 1711-1727
Synthesis and Degradation of Schiff Bases Containing Heterocyclic Pharmacophore
This paper reports on the synthesis and characterization of two Schiff bases bearing 1,2,4-triazolic moieties, namely 4H-4-(2-hydroxy-benzylidene-amino)-5-benzyl-3-mercapto-1,2,4-triazole and 4H-4-(4-nitro-benzylidene-amino)-5-benzyl-3-mercapto-1,2,4-triazole using thin layer chromatography, melting interval, elemental analysis, spectroscopy and thermal stability studies.
- 13 January 2015
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 16 (1) , 1711-1727
Open AccessSynthesis and Degradation of Schiff Bases Containing Heterocyclic Pharmacophore
This paper reports on the synthesis and characterization of two Schiff bases bearing 1,2,4-triazolic moieties, namely 4H-4-(2-hydroxy-benzylidene-amino)-5-benzyl-3-mercapto-1,2,4-triazole and 4H-4-(4-nitro-benzylidene-amino)-5-benzyl-3-mercapto-1,2,4-triazole using thin layer chromatography, melting interval, elemental analysis, spectroscopy and thermal stability studies.